FORM 3
        	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
	OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

Daly Jason B.	2. Date of Event Requiring Statement (MM/DD/YYYY)
1/17/2022 
	3. Issuer Name and Ticker or Trading Symbol

Amneal Pharmaceuticals, Inc. [AMRX]	
(Last)       (First)       (Middle)

C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD	4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
SVP, Chief Legal Officer /	
(Street)

BRIDGEWATER, NJ 08807      

(City)             (State)             (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY)
 
	6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Beneficially Owned	
1.Title of Security
(Instr. 4)	2. Amount of Securities Beneficially Owned
(Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)	4. Nature of Indirect Beneficial Ownership
(Instr. 5)	
No securities are beneficially owned 	0 	D 	 	

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 4)	2. Date Exercisable and Expiration Date
(MM/DD/YYYY)	3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)	6. Nature of Indirect Beneficial Ownership
(Instr. 5)	
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares				

Explanation of Responses:	

Remarks:
Exhibit 24 - Power of Attorney	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
Daly Jason B.
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD
BRIDGEWATER, NJ 08807			SVP, Chief Legal Officer		

Signatures		
/s/ Meredith Cook, as attorney-in-fact		1/26/2022	
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.	

                               POWER OF ATTORNEY

     Know all by these presents, that the undersigned hereby constitutes and
appoints each of (i) the Chief Financial Officer of Amneal Pharmaceuticals,
Inc., a Delaware corporation (the "Company") and who is currently Anastasios
Konidaris (ii) the Company's Associate General Counsel, who is currently
Meredith Cook, and (iii) the Company's Chief Human Resources Officer, who is
currently Nikita Shah, and their respective successors (including anyone serving
in such capacities on an interim or acting basis), signing singly, with full
powers of substitution, as the undersigned's true and lawful attorney-in-fact
to:

  1. prepare, execute in the undersigned's name and on the undersigned's
     behalf, and submit to the U.S. Securities and Exchange Commission (the
     "SEC") a Form ID, including amendments thereto, and any other documents
     necessary or appropriate to obtain codes and passwords enabling the
     undersigned to make electronic filings with the SEC of reports required by
     Section 16(a) of the Securities Exchange Act of 1934 or any rule or
     regulation of the SEC;
  2. execute for and on behalf of the undersigned, in the undersigned's
     capacity as an officer and/or director of the Company, and/or 10% holder of
     the Company's capital stock, Forms 3, 4, and 5 and any amendments thereto
     in accordance with Section 16(a) of the Securities Exchange Act of 1934 and
     the rules thereunder;
  3. do and perform any and all acts for and on behalf of the undersigned
     which may be necessary or desirable to complete and execute any such Form
     3, 4, or 5, complete and execute any amendment or amendments thereto, and
     timely file such form with the SEC and any stock exchange or similar
     authority; and
  4. take any other action of any type whatsoever in connection with the
     foregoing which, in the opinion of such attorney-in-fact, may be of benefit
     to, in the best interest of, or legally required by, the undersigned, it
     being understood that the documents executed by such attorney-in-fact on
     behalf of the undersigned pursuant to this Power of Attorney shall be in
     such form and shall contain such terms and conditions as such attorney-in-
     fact may approve in such attorney-in-fact's discretion.

     The undersigned hereby grants to each such attorney-in-fact full power and
     authority to do and perform any and every act and thing whatsoever
     requisite, necessary, or proper to be done in the exercise of any of the
     rights and powers herein granted, as fully to all intents and purposes as
     the undersigned might or could do if personally present, with full power of
     substitution or revocation, hereby ratifying and confirming all that such
     attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
     shall lawfully do or cause to be done by virtue of this power of attorney
     and the rights and powers herein granted. The undersigned acknowledges that
     the foregoing attorneys-in-fact, in serving in such capacity at the request
     of the undersigned, are not assuming, nor is the Company assuming, any of
     the undersigned's responsibilities to comply with Section 16 of the
     Securities Exchange Act of 1934.

     This Power of Attorney shall remain in full force and effect until the
     undersigned is no longer required to file Forms 3, 4, and 5 with respect to
     the undersigned's holdings of and transactions in securities issued by the
     Company, unless earlier revoked by the undersigned in a signed writing
     delivered to the foregoing attorneys-in-fact.

   IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 25th day of January 2022.

              /s/ Jason B. Daly
              ----------------------------------
              By: Jason B. Daly